China approves a new, home-grown Alzheimer’s drug—and questions immediately follow – FiercePharma

Since Allergans Namenda FDA nod in late 2003, the world hasnt seen an approved Alzheimers disease new drug for 17 years. That drought was broken Saturday, not by a Western biopharma bigwig, but by a little-known Chinese firm.
Chinas drug regulator on Saturda…

Click here to view the original article.